DataCentersX > Workloads > Regulated Industries > Healthcare
DC Healthcare Workloads
Healthcare workloads sit in the Regulated Industries cluster because patient data regulation, clinical software validation, and care-delivery reliability requirements materially shape datacenter design. The workload profile is primarily data-sensitivity-driven rather than performance-driven: medical imaging archives, electronic health records, clinical decision support systems, and genomic datasets all demand strong encryption, strict access controls, long retention periods, and demonstrable audit trails more than they demand the high-density compute that characterizes AI training or HPC workloads.
The exception is the fast-growing area of AI in clinical care. AI models trained on imaging, pathology, genomics, and longitudinal EHR data are reshaping the healthcare compute profile. Training runs on de-identified clinical datasets now require AI-scale compute infrastructure, and inference deployment into hospital and clinic workflows introduces new regulatory territory around FDA clearance of Software as a Medical Device. These workloads sit at the intersection of healthcare regulation and AI infrastructure, and they pull parts of the healthcare workload profile toward the AI training and inference end of the DX taxonomy.
Regulatory frameworks
| Framework | Scope | Primary Datacenter Impact |
|---|---|---|
| HIPAA and HITECH | US patient health information (PHI) | Encryption at rest and in flight, access controls, audit logging, BAA chains, breach notification obligations |
| 21 CFR Part 11 | FDA-regulated electronic records for clinical trials and pharma | Electronic signature validation, immutable audit trails, system validation documentation |
| GxP (GLP, GCP, GMP) | Pharmaceutical research, clinical trials, and manufacturing | Validated systems, change control, qualification documentation (IQ/OQ/PQ) |
| GDPR (for EU patient data) | Health data of EU residents | Data residency, explicit consent management, right-to-erasure infrastructure |
| HITRUST CSF | Voluntary certification framework aligning multiple healthcare regulations | Increasingly required by healthcare enterprises of their cloud and colocation providers |
| FDA SaMD guidance | Software as a Medical Device, including AI/ML-based clinical tools | Model validation, predetermined change control plans, post-market surveillance infrastructure |
Workload categories
Healthcare workloads fall into several structurally distinct classes, each with different performance, storage, and regulatory profiles.
Electronic Health Records (EHR). The core clinical transaction system, dominated at scale by Epic and Cerner (Oracle Health). EHR workloads are latency-sensitive during clinical interactions (sub-second response for bedside queries) but are not compute-intensive in the AI sense. The infrastructure profile is high-availability OLTP database tiers, redundant application servers, and large but not massive storage volumes. The regulatory load is substantial: every access is logged, every change is audited, and retention extends for years or decades depending on jurisdiction.
Medical imaging and PACS. Picture Archiving and Communication Systems store radiology, pathology, and other imaging modalities. Individual studies range from megabytes (CT slice) to gigabytes (whole-slide pathology or multi-parametric MRI). Aggregate storage at a large health system scales to multiple petabytes, with retention periods of years for regulatory reasons and effectively forever for many longitudinal patient cohorts. The datacenter profile favors dense cost-effective storage tiers with reliable archival backends.
Genomic data infrastructure. Whole-genome sequencing produces roughly 100 to 200 GB per patient; large research cohorts and population-scale sequencing programs produce petabytes per year. Genomic workloads combine storage scale with bursty compute for alignment, variant calling, and increasingly AI-based variant interpretation. Clinical-grade genomic workflows add regulatory constraints around chain of custody from sample to report.
Clinical decision support and AI in care. AI models trained on imaging, EHR, pathology, and multi-modal datasets are being deployed into diagnostic and clinical workflow tools. Training runs increasingly require AI-scale infrastructure with GPU fleets and fast storage, running on de-identified clinical datasets to meet HIPAA Safe Harbor or Expert Determination standards. Inference runs either in the healthcare organization's own datacenter (on-premise for latency and data residency) or in sovereign cloud regions with BAA coverage.
Pharmaceutical research compute. Drug discovery, molecular dynamics simulation, protein structure prediction, and increasingly AI-accelerated compound screening. These workloads are HPC and AI training in character, but operate under GxP change control and validation expectations that non-pharma research compute does not face.
Medical billing and revenue cycle. Adjacent to core clinical workloads but with their own regulatory profile including PCI-DSS where payment data is involved, payer-specific EDI standards, and the same HIPAA coverage as clinical systems.
De-identification and AI training
Training AI models on clinical data requires either patient consent at scale (operationally impractical for most training sets) or de-identification sufficient to remove the data from HIPAA jurisdiction. HIPAA provides two pathways: Safe Harbor, which specifies removal of eighteen specific identifier categories, and Expert Determination, which allows an expert to certify that re-identification risk is sufficiently low for the specific dataset and use case. Both pathways produce technical requirements that shape the datacenter environment.
Most large healthcare AI programs run a dedicated de-identification enclave where raw PHI enters, de-identification runs under full HIPAA controls, and de-identified outputs exit to a training environment with lighter restrictions. The enclave itself is a fully regulated environment, while the training environment downstream can operate with standard AI infrastructure controls. This separation is a common design pattern across academic medical centers, pharma research, and healthcare AI startups.
Genomic data complicates the picture because genomes are inherently identifying and cannot be fully de-identified under Safe Harbor. Genomic AI training therefore typically requires explicit consent, controlled-access repositories, or federated approaches that never move raw data out of the originating institution. Federated learning infrastructure, where model updates are shared but training data is not, is an emerging architectural pattern in healthcare AI for exactly this reason.
Where healthcare workloads run
Healthcare compute deploys across several datacenter types, with the mix driven by regulatory posture, institutional IT maturity, and workload profile.
| Deployment Context | Typical Workloads | Regulatory Profile |
|---|---|---|
| On-premise hospital datacenter | EHR production, imaging archives, inference at the point of care | Full HIPAA control; institution bears primary accountability |
| Sovereign cloud region (AWS HIPAA, Azure healthcare, GCP healthcare) | Analytics, ML training, EHR cloud deployments, research compute | BAA with cloud provider; shared responsibility model |
| Healthcare-specific colocation | Regional health information exchanges, multi-tenant clinical SaaS | Colocation provider offers HITRUST-certified environment |
| Academic medical center research compute | Research cohorts, genomics, clinical AI model training | IRB oversight, Common Rule, and HIPAA research provisions |
| Pharma enterprise research | Drug discovery HPC, molecular simulation, AI-accelerated screening | GxP validation regime alongside HIPAA for any human-subject data |
AI in care: the emerging regulatory territory
Clinical AI models that influence diagnosis, treatment, or care delivery fall under FDA medical device regulation as Software as a Medical Device. The datacenter implications are twofold. First, the training infrastructure has to produce validated, reproducible, auditable model artifacts that can be submitted for FDA clearance. Second, the inference deployment has to operate within a predetermined change control plan that governs how the model can be updated post-clearance without requiring re-submission.
The practical consequence is that clinical AI datacenter environments need model lineage tracking, training dataset provenance, hyperparameter and configuration audit trails, and inference monitoring for distribution drift and performance degradation that go beyond what general-purpose AI infrastructure provides. MLOps tooling in healthcare is becoming its own category, with validation requirements closer to pharma GxP software than to typical cloud-native ML pipelines.
Related coverage
Regulated Industries | Government and Defense | Financial Services | Energy and Utilities | Workloads | Enterprise Apps | AI Inference | AI Training | Data Sovereignty | Compliance